*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Everolimus is a potent <strong>mTOR inhibitor</strong> synthesized via fermentation and semi-synthesis. It serves as a key immunosuppressant and anti-neoplastic agent. The compound features the molecular formula <strong>C<sub>53</sub>H<sub>83</sub>NO<sub>14</sub></strong> with CAS number <strong>159351-69-0</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology:</strong> Treatment of renal cell carcinoma, breast cancer, and neuroendocrine tumors.</li>
<li><strong>Transplantation:</strong> Prevention of organ rejection in kidney transplant recipients.</li>
<li><strong>Cardiology:</strong> Coating for drug-eluting stents to prevent restenosis.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated during pregnancy due to teratogenicity. Requires storage at controlled room temperature (20-25°C) protected from light and moisture. Personnel must utilize appropriate PPE to avoid dermal exposure.</p>